GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Shortwave Life Sciences PLC (AQSE:PSY) » Definitions » Capex-to-Operating-Income

Shortwave Life Sciences (AQSE:PSY) Capex-to-Operating-Income : 0.00 (As of . 20)


View and export this data going back to 2022. Start your Free Trial

What is Shortwave Life Sciences Capex-to-Operating-Income?

Capex-to-Operating-Income measures a company's investments in physical assets such as property, industrial buildings or equipment to its operating income.

Shortwave Life Sciences's Capital Expenditure for the six months ended in . 20 was £0.00 Mil. Its Operating Income for the six months ended in . 20 was £0.00 Mil.

GuruFocus do not calculate Capex-to-Operating-Income if the Operating Income is negative.


Shortwave Life Sciences Capex-to-Operating-Income Historical Data

The historical data trend for Shortwave Life Sciences's Capex-to-Operating-Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shortwave Life Sciences Capex-to-Operating-Income Chart

Shortwave Life Sciences Annual Data
Trend
Capex-to-Operating-Income

Shortwave Life Sciences Semi-Annual Data
Capex-to-Operating-Income

Competitive Comparison of Shortwave Life Sciences's Capex-to-Operating-Income

For the Biotechnology subindustry, Shortwave Life Sciences's Capex-to-Operating-Income, along with its competitors' market caps and Capex-to-Operating-Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shortwave Life Sciences's Capex-to-Operating-Income Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Shortwave Life Sciences's Capex-to-Operating-Income distribution charts can be found below:

* The bar in red indicates where Shortwave Life Sciences's Capex-to-Operating-Income falls into.


;
;

Shortwave Life Sciences Capex-to-Operating-Income Calculation

Shortwave Life Sciences's Capex-to-Operating-Income for the fiscal year that ended in . 20 is calculated as

Capex-to-Operating-Income=- Capital Expenditure / Operating Income
=- () /
=N/A

Shortwave Life Sciences's Capex-to-Operating-Income for the quarter that ended in . 20 is calculated as

Capex-to-Operating-Income=- Capital Expenditure / Operating Income
=- () /
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Shortwave Life Sciences  (AQSE:PSY) Capex-to-Operating-Income Explanation

Capex-to-Operating-Income assesses how much emphasis a company is placing upon investing in capital-intensive projects. The ratio is generally a good gauge to quantify how much focus on growth a company has. Typically, smaller companies that are still growing and expanding will have a higher Capex to Operating Income Ratio, since such businesses are likely investing more in physical assets. Lower ratios could indicate that a company has reached maturity and it is no longer pursuing aggressive growth.


Shortwave Life Sciences Capex-to-Operating-Income Related Terms

Thank you for viewing the detailed overview of Shortwave Life Sciences's Capex-to-Operating-Income provided by GuruFocus.com. Please click on the following links to see related term pages.


Shortwave Life Sciences Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
17 Hanover Square, London, GBR, W1S 1BN
Shortwave Life Sciences PLC is a biopharmaceutical company focused in advancing pioneering therapies in mental health care, also it is involved in developing novel drug combinations and delivery methods to treat patients suffering from mental health disorders. It identifies, operates and creates value from early-stage, breakthrough initiatives, with an initial focus on eating disorders.

Shortwave Life Sciences Headlines